Bayesian Capital Management’s Opko Health OPK Stock Holding History

Bayesian Capital Management’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-57,700	Closed	-$72.1K	–	1013
2022 Q4	$72.1K	Buy	+57,700	New	+$90.9K	0.01%	688
2022 Q3	–	Sell	-33,700	Closed	-$85K	–	939
2022 Q2	$85K	Buy	+33,700	New	+$98.3K	0.02%	695
2019 Q1	–	Sell	-60,600	Closed	-$182K	–	701
2018 Q4	$182K	Buy	60,600 +20,600	+52%	+$69.8K	0.04%	528
2018 Q3	$138K	Buy	+40,000	New	+$212K	0.02%	578
2016 Q4	–	Sell	-18,500	Closed	-$196K	–	672
2016 Q3	$196K	Buy	+18,500	New	+$184K	0.13%	287
2016 Q1	–	Sell	-12,366	Closed	-$124K	–	417
2015 Q4	$124K	Buy	+12,366	New	+$124K	0.18%	208

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bayesian Capital Management's OPK Position: Q1 2023 in Review

Bayesian Capital Management sold out of Opko Health (OPK) in Q1 2023, closing a stake of 57,700 shares — an estimated $72.1K sold.

Bayesian Capital Management first reported a position in OPK in Q4 2015 and held it in 6 quarters. The position peaked at $196K in Q3 2016. 227 funds tracked by Wall St. Rank hold OPK as of Q1 2023.

Bayesian Capital Management reported no remaining Opko Health position as of Q1 2023 after selling out during the quarter.
Bayesian Capital Management sold 57,700 Opko Health shares in Q1 2023, an estimated $72.1K.
Bayesian Capital Management first reported a position in Opko Health in Q4 2015 and held it in 6 quarters.
Bayesian Capital Management's Opko Health position peaked at $196K in Q3 2016.
227 funds tracked by Wall St. Rank held Opko Health as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.